From: Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial
∆CES-D | ∆IL-1β | ∆TRP/LNAA | ∆KYN/TRP | |
---|---|---|---|---|
All participants (n = 20) | ||||
∆CES-D | – | – | – | – |
∆IL-1β | 0.740** | – | – | – |
∆TRP/LNAA | −0.378 | 0.369 | – | – |
∆KYN/TRP | 0.586** | 0.536* | 0.345 | – |
∆KYN | 0.705** | 0.657** | 0.114 | 0.730** |
Subgroup (CES-D > 16) (n = 8) | ||||
∆CES-D | – | – | – | – |
∆IL-1β | 0.738* | – | – | – |
∆TRP/LNAA | 0.569 | 0.363 | – | – |
∆KYN/TRP | 0.937** | 0.792* | 0.436 | – |
∆KYN | 0.800** | 0.825** | 0.192 | 0.823** |